Synthekine: Synthekine collaborates with Sanofi to develop selective IL10 agonists to treat inflammatory diseases
Synthekine Inc., an engineered cytokine therapeutics company, announced a worldwide collaboration with Sanofi to develop and commercialize IL─10 receptor agonists for the treatment of inflammatory diseases.
Read full article »
Synthekine is a California-based biotechnology company that develops cytokine therapeutics for the treatment of cancer and inflammatory diseases.
Read more